Published in Science on July 01, 1983
Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest (1995) 1.47
Characterization of bovine tracheobronchial phenol sulphotransferase cDNA and detection of mRNA regulation by cortisol. Biochem J (1995) 0.80
Tissue thyroid hormones and thyronamines. Heart Fail Rev (2016) 0.76
Metabolism of reverse triiodothyronine by isolated rat hepatocytes. J Clin Invest (1987) 0.76
Accumulation of plasma triiodothyronine sulfate in rats treated with propylthiouracil. J Clin Invest (1987) 0.76
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology (2000) 2.50
Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health (1998) 2.24
[As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease]. Ned Tijdschr Geneeskd (2003) 1.93
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J (1976) 1.57
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro. Eur J Endocrinol (1998) 1.41
[Cardiovascular effects of hyperthyroidism and their treatment]. Ned Tijdschr Geneeskd (2002) 1.39
[Does no Helicobacter pylori mean no duodenal ulcer?]. Ned Tijdschr Geneeskd (1993) 1.39
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver. J Nucl Med (1993) 1.38
Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc Natl Acad Sci U S A (1982) 1.37
Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol (1993) 1.34
Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J Clin Invest (1983) 1.30
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med (2001) 1.30
Cerebral cortex responds rapidly to thyroid hormones. Science (1981) 1.29
Modulation of aggression in male mice: influence of group size and cage size. Physiol Behav (2001) 1.24
In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol (1998) 1.22
Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab (2001) 1.20
Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology (1996) 1.20
Sequential deiodination of thyroxine in rat liver homogenate. Biochem J (1978) 1.18
Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci Res (1995) 1.16
Inhibition of thyroid hormone sulfation by hydroxylated metabolites of polychlorinated biphenyls. Chem Biol Interact (1998) 1.15
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology (2001) 1.12
Chronic stress in dogs subjected to social and spatial restriction. II. Hormonal and immunological responses. Physiol Behav (1999) 1.12
Large body size in the dog is associated with transient GH excess at a young age. J Endocrinol (2001) 1.11
Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. Gen Comp Endocrinol (1994) 1.11
Thyroid hormone transporters. Biochem Soc Trans (2005) 1.10
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Chronic stress in dogs subjected to social and spatial restriction. I. Behavioral responses. Physiol Behav (1999) 1.09
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab (1998) 1.08
Mechanism of action of iodothyronine-5'-deiodinase. Biochim Biophys Acta (1979) 1.08
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med (2001) 1.07
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab (2008) 1.06
Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology (2005) 1.05
Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol (Oxf) (1981) 1.05
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med (1997) 1.04
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur J Nucl Med (1999) 1.04
A tentative review of recent in vitro observations of the enzymatic deiodination of iodothyronines and its possible physiological implications. Mol Cell Endocrinol (1978) 1.04
The use of saliva cortisol, urinary cortisol, and catecholamine measurements for a noninvasive assessment of stress responses in dogs. Horm Behav (1996) 1.03
Combined pituitary hormone deficiency in german shepherd dogs with dwarfism. Domest Anim Endocrinol (2000) 1.03
Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochem J (1979) 1.03
Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology (1999) 1.02
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology (1991) 1.01
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Identification of thyroid hormone transporters. Biochem Biophys Res Commun (1999) 1.00
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol (1992) 0.99
Regulation of thyroid hormone metabolism during fetal development. Mol Cell Endocrinol (1999) 0.98
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med (1997) 0.97
Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. Endocrinology (1984) 0.97
Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochim Biophys Acta (1979) 0.97
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol (2006) 0.96
Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett (1994) 0.96
Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. J Clin Endocrinol Metab (2001) 0.95
Different pathways of iodothyronine 5'-deiodination in rat cerebral cortex. Biochem Biophys Res Commun (1981) 0.95
Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology (1985) 0.94
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology (1994) 0.94
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology (1993) 0.94
Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential. J Physiol Pharmacol (2009) 0.94
Interlaboratory variation of vitamin D1) metabolite measurements. J Clin Chem Clin Biochem (1982) 0.94
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history. Ann N Y Acad Sci (1994) 0.94
Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci (1984) 0.93
Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology (1985) 0.93
Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. J Physiol Pharmacol (2009) 0.93
Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) (2008) 0.92
Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab (2000) 0.92
Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology (2003) 0.92
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid (2004) 0.91
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2011) 0.91
Comparison of cellular and tissue transcriptional profiles in canine mammary tumor. J Physiol Pharmacol (2009) 0.91
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (1998) 0.91
Substrate requirement for inactivation of iodothyronine-5'-deiodinase activity by thiouracil. Biochim Biophys Acta (1981) 0.91
Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol (1997) 0.91
Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol (1977) 0.90
Photophysics of the single tryptophan residue in Fusarium solani Cutinase: evidence for the occurrence of conformational substates with unusual fluorescence behaviour. Biophys Chem (1996) 0.90
In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: isozyme specificity and inhibition kinetics. Toxicol Sci (1998) 0.90
Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab (1996) 0.90
Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism. Vet Rec (2003) 0.90
Hypothalamo-hypophysial-thyroid axis in streptozotocin-induced diabetes. Endocrinology (1992) 0.89
Nanoscale control of graphene electrodes. Phys Chem Chem Phys (2014) 0.89
Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology (1994) 0.89
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med (1996) 0.89
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (2000) 0.88
Rat liver type I iodothyronine deiodinase is not identical to protein disulfide isomerase. Biochem Biophys Res Commun (1989) 0.88
Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. Eur J Endocrinol (2009) 0.88
Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J (Clin Res Ed) (1981) 0.87
Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab (1999) 0.87
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients. Ann Rheum Dis (2013) 0.87
Pituitary function and morphology in two German shepherd dogs with congenital dwarfism. Vet Rec (1999) 0.87
One enzyme for the 5'-deiodination of 3,3',5'-triiodothyronine and 3',5'-diiodothyronine in rat liver. Biochem Pharmacol (1982) 0.87
Disturbed release of growth hormone in mature dogs: a comparison with congenital growth hormone deficiency. Vet Rec (1993) 0.86